How do you pay?
Which strength?
How many tablets?

How to pay the least

Cash price

$4,090+ for 30 tablets

Pharmacies pay about this for Biktarvy; you’d pay more.

What to do

  1. Ask your pharmacy for Biktarvy’s cash price, and one or two other pharmacies too.
  2. Biktarvy’s savings card works only with insurance from a job or one you bought.

Other ways

Free from the maker, if you qualify Advancing Access Patient Assistance Program/Medication Assistance Program (PAP/MAP). Or call 1-800-226-2056.

See if you qualify 

No generic is sold yet.

Compare every option

Brand name

Biktarvy, the original

At least$4,090for 30 tablets; pharmacies pay this
Ways to save on Biktarvy

The maker’s card

Gilead Advancing Access Co-pay Savings Program

Savings card from Gilead Sciences

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $7,200 a year off your co-pay.

Sign up on biktarvyhcp.com 

Or call 1-800-226-2056.

In the maker’s words

“Eligible, commercially insured individuals enrolled in Gilead Advancing Access co-pay coupon card program could pay as little as $0.”

From the maker’s offer on biktarvyhcp.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

No generic is sold yet.

Not soldNone sold yet

What it’s used for

What the FDA label says

BIKTARVY is a three-drug combination of bictegravir (BIC), a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs), and is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 14 kg:

  • with no antiretroviral treatment history or
  • with an antiretroviral treatment history and not virologically suppressed, with no known or suspected substitutions associated with resistance to the integrase strand inhibitor class, emtricitabine, or tenofovir, or
  • to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no known or suspected substitutions associated with resistance to bictegravir or tenofovir.

Source: the FDA label for Biktarvy (Gilead Sciences, Inc.), September 9, 2026. Full label on DailyMed 

Good to know

  • “Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
  • Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.